Lennart D Johns1, Stephen J Straub, Samuel M Howard. 1. Department of Physical Therapy, Athletic Training/Sports Medicine Program, Quinnipiac University, Hamden, CT, USA. Lenn.Johns@quinnipiac.edu
Abstract
OBJECTIVE: To characterize the ultrasound fields produced by a cohort of transducers from a single manufacturer via hydrophone and Schlieren technology. DESIGN: Descriptive study. SETTING: Measurement laboratory. PARTICIPANTS: Seven same-model ultrasound transducers from a single manufacturer. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Effective radiating area (ERA), total power, spatial average intensity (SAI), beam nonuniformity ratio (BNR), and Schlieren beam widths at 1.0 and 3.3 MHz. RESULTS: Values for ERA (1.0 MHz range, 3.62-4.38 cm(2); 3.3 MHz range, 3.74-4.76 cm(2)), total power (1.0 MHz range, 5.0-5.6 W; 3.3 MHz range, 4.7-5.7 W), SAI (1.0 MHz range, 1.2-1.4 W/cm(2); 3.3 MHz range, 1.0-1.5 W/cm(2)), and BNR (1.0 MHz range, 2.79-5.85; 3.3 MHz range, 2.51-4.56) fell within manufacturer's specifications and U.S. Food and Drug Administration (FDA) regulations. Schlieren analysis showed significantly larger beam widths at 3.3 MHz compared with 1.0 MHz and a large degree of variability in the ultrasound fields generated by the different transducers. There were no significant correlations between beam widths and ERA values. CONCLUSIONS: ERA and total power values in a test cohort exist within a range that met FDA regulations. Individual variability in ERA and total power resulted in 50% variability in SAI. This variability may help explain previous reports of heating differences between transducers.
OBJECTIVE: To characterize the ultrasound fields produced by a cohort of transducers from a single manufacturer via hydrophone and Schlieren technology. DESIGN: Descriptive study. SETTING: Measurement laboratory. PARTICIPANTS: Seven same-model ultrasound transducers from a single manufacturer. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Effective radiating area (ERA), total power, spatial average intensity (SAI), beam nonuniformity ratio (BNR), and Schlieren beam widths at 1.0 and 3.3 MHz. RESULTS: Values for ERA (1.0 MHz range, 3.62-4.38 cm(2); 3.3 MHz range, 3.74-4.76 cm(2)), total power (1.0 MHz range, 5.0-5.6 W; 3.3 MHz range, 4.7-5.7 W), SAI (1.0 MHz range, 1.2-1.4 W/cm(2); 3.3 MHz range, 1.0-1.5 W/cm(2)), and BNR (1.0 MHz range, 2.79-5.85; 3.3 MHz range, 2.51-4.56) fell within manufacturer's specifications and U.S. Food and Drug Administration (FDA) regulations. Schlieren analysis showed significantly larger beam widths at 3.3 MHz compared with 1.0 MHz and a large degree of variability in the ultrasound fields generated by the different transducers. There were no significant correlations between beam widths and ERA values. CONCLUSIONS: ERA and total power values in a test cohort exist within a range that met FDA regulations. Individual variability in ERA and total power resulted in 50% variability in SAI. This variability may help explain previous reports of heating differences between transducers.
Authors: Michale G Miller; Janae R Longoria; Christopher C Cheatham; Robert J Baker; Timothy J Michael Journal: J Sports Sci Med Date: 2008-06-01 Impact factor: 2.988
Authors: Jae Youn Hwang; Hae Gyun Lim; Chi Woo Yoon; Kwok Ho Lam; Sangpil Yoon; Changyang Lee; Chi Tat Chiu; Bong Jin Kang; Hyung Ham Kim; K Kirk Shung Journal: Ultrasound Med Biol Date: 2014-07-09 Impact factor: 2.998